Harvard Business Review

JUNE 20, 2017

For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.

Company 15

Company Agility Innovation Learning-by-Doing 15

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium. How did the city make the leap?

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Risk and outcomes, as the scenario plays out, will be managed by predictive models, which are powered by machine learning algorithms that will improve their accuracy rates over time.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. That can be a powerful marketing technique if you have the market muscle to pull it off. Then to your credit, you bring up the paradox yourself. What's up with that? I think people misunderstand Apple.

Supply Chain 15

Supply Chain Open-book Software Niche Marketing 15

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Innovators developing new drugs, devices, and procedures should look beyond profits alone and incorporate the need to add value into their investments.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MARCH 27, 2018

Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. Is it OK for a few firms to possess so much data and thereby wield so much power? In the U.S.,

Company 11

Company Advertising Incentives Engineering 11

Harvard Business Review

FEBRUARY 4, 2013

Most of us would say it's exceptionally hard, particularly when power is concentrated in a few incumbent companies with deeply rooted vested interests. But this focused power may be a benefit, not a risk. Perhaps surprisingly, two leading examples come from pharmaceutical companies. planets-and-counting forms of capitalism?

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

OCTOBER 24, 2017

These have forced AirBnB, Tesla, and Uber to make costly concessions to their operating practices or to exit certain markets altogether. Organized demonstrations of support by stakeholder groups can send a powerful signal to policymakers. How can new firms overcome the regulations that protect incumbents? Consumer clubs.

Licensing 10

Licensing Proposal Retail Long-term 10

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Google uses a different approach to working with multiple external parties.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

MARCH 25, 2016

Mapping out all the steps a customer takes while interacting with your company is a powerful way to improve the experience. A few years ago, I worked with a large pharmaceutical client who wanted to improve how patients with an incurable disease self-injected their drug. That’s understandable.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Hotels Proposal 8

Harvard Business Review

OCTOBER 26, 2011

When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive. Since energy startups operate in an ecosystem dominated by incumbents, they can benefit dramatically from use of incumbent resources.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

MARCH 11, 2013

Apple is probably the most successful and innovative company on earth over the past decade, and it's extremely closed and secretive. That can be a powerful marketing technique if you have the market muscle to pull it off. Then to your credit, you bring up the paradox yourself. What's up with that? I think people misunderstand Apple.

Supply Chain 8

Supply Chain Open-book Software Niche Marketing 8

Harvard Business Review

SEPTEMBER 26, 2011

Some people may contend that given the high risks and many years it takes to develop a new drug, pharmaceutical companies are different animals from other firms. The fundamental challenges that CEOs of drug companies face are similar to those of any CEO: innovate, manage risk and uncertainty, and create long-term firm value.

CEO 15

CEO Short-term Long-term Restructuring 15

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 13

Innovation Supply Chain Offshoring Policies 13

Harvard Business Review

NOVEMBER 28, 2017

Doing so entails operating more efficiently or innovating to create products that consumers value more. Anyone who owns or operates a business is well acquainted with the risks, sacrifices, and competitive pressures involved. They may need reminders of their enormous collective power and influence.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families. Making routine transactions seamless and reliable.

Health Care 10

Health Care Retail Operations Insurance 10

Harvard Business Review

MAY 28, 2015

Instead, according to new research from the Center for Talent Innovation (CTI), the fundamental issue is the health care industry’s failure to develop a nuanced understanding of, and commitment to, women as consumers and decision makers. Surprisingly, it’s not the cost of care.

Health Care 8

Health Care Industry First-mover Advantage Market Segmentation 8

Harvard Business Review

JUNE 24, 2015

It’s not that we lack powerful ways to approach strategy; it’s that we lack a robust way to select the right ones for the right circumstances. The f ive forces framework for strategy may be valid in one arena, blue ocean or open innovation in another, but each approach to strategy tends to be presented or perceived as a panacea.

Strategy 8

Strategy Competitive Advantage Environment Execution 8

Harvard Business Review

AUGUST 5, 2013

A pharmaceuticals company we''ve been studying decided to deploy more than 20,000 iPads and other mobile devices to the global sales force to improve its engagement with doctors in emerging and developed markets. Today''s CIO Needs to Be the Chief Innovation Officer. The Real Power of Enterprise Social Media Platforms.

Organization 8

Organization CIO Compliance CRM 8

Harvard Business Review

JULY 20, 2017

The innovation alone is a herculean task, but imagine being that upstart pioneer trying to develop the technology, while at the same time going up against entrenched, powerful competitors with deep industry knowledge, assets, and channels who’ve been around for a hundred years or more. This is an incredible moment for innovation.

Innovation 13

Innovation Productivity Products Venture Capitalist 13

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Customers Innovation Technology'

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

MARCH 6, 2015

Mark, a ten-year veteran of the pharmaceutical R&D world with a Ph.D. Post-heroic leaders recognize that the key to success is not adhering to hierarchy or position power, but mastering a complex set of seemingly contradictory organizational dynamics—autonomy and shared decision-making, individuality and teamwork.

Management 8

Management Self-aware Teamwork Pharmaceuticals 8